Acorda Therapeutics, Inc.:企業の戦略・SWOT・財務分析

MarketLineが発行した調査報告書(SWOT20MY4632)
◆英語タイトル:Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4632
◆発行会社(リサーチ会社):MarketLine
◆発行日:2020年2月
◆ページ数:48
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketLine社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Acorda Therapeutics, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Acorda Therapeutics, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Acorda Therapeutics (Acorda or ‘the company’) is a commercial-stage biotechnology company. It is engaged in the development and marketing of therapies to help restore function in persons with spinal cord injury, multiple sclerosis and related conditions of the central nervous system. The company also offers various pipeline products to neurological therapies including heart failure, migraine, Primary Sclerosing Cholangitis, MS, spinal cord injury and various other disorders. Acorda’s product portfolio are marketed under Zanaflex, Ampyra or Fampyra (dalfampridine); and Qutenza.The company primarily operates in the US, where it is headquartered in Ardsley, New York.

Scope

- Detailed information on Acorda Therapeutics, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Acorda Therapeutics, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Acorda Therapeutics, Inc. including a breakdown and examination of key business segments
- Intelligence on Acorda Therapeutics, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Acorda Therapeutics, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Acorda Therapeutics, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Acorda Therapeutics, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Acorda Therapeutics, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Acorda Therapeutics, Inc.: Company Overview
Acorda Therapeutics, Inc.: Overview and Key Facts
Acorda Therapeutics, Inc.: Overview
Acorda Therapeutics, Inc.: Key Facts
Acorda Therapeutics, Inc.: Key Employees
Acorda Therapeutics, Inc.: Key Employee Biographies
Acorda Therapeutics, Inc.: Major Products and Services
Acorda Therapeutics, Inc.: Company History
Acorda Therapeutics, Inc.: Management Statement
Acorda Therapeutics, Inc.: Locations and Subsidiaries
Acorda Therapeutics, Inc.: Key Competitors
Acorda Therapeutics, Inc.: Company Analysis
Acorda Therapeutics, Inc.: Business Description
Acorda Therapeutics, Inc.: SWOT Analysis
Acorda Therapeutics, Inc.: SWOT Overview
Acorda Therapeutics, Inc.: Strengths
Acorda Therapeutics, Inc.: Weaknesses
Acorda Therapeutics, Inc.: Opportunities
Acorda Therapeutics, Inc.: Threats
Acorda Therapeutics, Inc.: Corporate Financial Deals Activity
Acorda Therapeutics, Inc.: Financial Deals Overview
Acorda Therapeutics, Inc.: Targets and Partners
Acorda Therapeutics, Inc.: Top Deals 2016 – 2020YTD*
Acorda Therapeutics, Inc.: Advisors
Acorda Therapeutics, Inc.: Top Legal Advisors
Acorda Therapeutics, Inc.: Top Financial Advisors
Acorda Therapeutics, Inc.: Mergers and Acquisitions
Acorda Therapeutics, Inc.: Divestments
Acorda Therapeutics, Inc.: Private Equity and Ownership
Acorda Therapeutics, Inc.: Recent Developments
Acorda Therapeutics, Inc.: News and Events Summary
Acorda Therapeutics, Inc.: Business Reorganization
Acorda Therapeutics, Inc.: Contracts
Acorda Therapeutics, Inc.: Corporate Governance
Acorda Therapeutics, Inc.: Financial Performance
Acorda Therapeutics, Inc.: Market Developments
Acorda Therapeutics, Inc.: Red Flags/DistressSignals
Acorda Therapeutics, Inc.: Regulatory and Legal Events
Acorda Therapeutics, Inc.: Research & Development
Acorda Therapeutics, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Acorda Therapeutics, Inc.: Key Facts
Table 2: Acorda Therapeutics, Inc.: Key Employees
Table 3: Acorda Therapeutics, Inc.: Company History
Table 4: Acorda Therapeutics, Inc.: Locations and Subsidiaries
Table 5: Acorda Therapeutics, Inc.: Key Competitors
Table 6: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Acorda Therapeutics, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Acorda Therapeutics, Inc.: Targets and Partners
Table 9: Acorda Therapeutics, Inc.: Top Deals 2016 - 2020YTD*
Table 10: Acorda Therapeutics, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Acorda Therapeutics, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Acorda Therapeutics, Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Acorda Therapeutics, Inc.: M&A Activity by Geography (2016 - YTD*2020)
Table 14: Acorda Therapeutics, Inc.: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 15: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 16: Acorda Therapeutics, Inc.: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 17: Acorda Therapeutics, Inc.: News and Events Summary
Table 18: Acorda Therapeutics, Inc.: Business Reorganization
Table 19: Acorda Therapeutics, Inc.: Contracts
Table 20: Acorda Therapeutics, Inc.: Corporate Governance
Table 21: Acorda Therapeutics, Inc.: Financial Performance
Table 22: Acorda Therapeutics, Inc.: Market Developments
Table 23: Acorda Therapeutics, Inc.: Red Flags/DistressSignals
Table 24: Acorda Therapeutics, Inc.: Regulatory and Legal Events
Table 25: Acorda Therapeutics, Inc.: Research & Development
Table 26: Acorda Therapeutics, Inc.: Strategy and Operations

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Acorda Therapeutics, Inc.:企業の戦略・SWOT・財務分析(Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆